
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.69 | 5.96119929453 | 28.35 | 31 | 27.6427 | 1163523 | 29.6655862 | CS |
4 | -3.62 | -10.7546048723 | 33.66 | 34.14 | 27.6427 | 1282536 | 30.75847063 | CS |
12 | -2.51 | -7.71121351767 | 32.55 | 35.53 | 26.74 | 1358949 | 30.95727032 | CS |
26 | -10.42 | -25.7538309441 | 40.46 | 56 | 26.74 | 1314283 | 37.93319477 | CS |
52 | 8.74 | 41.0328638498 | 21.3 | 56 | 20.8 | 1310153 | 36.52459719 | CS |
156 | 11.96 | 66.1504424779 | 18.08 | 56 | 4.825 | 1096132 | 22.88671286 | CS |
260 | 3.54 | 13.358490566 | 26.5 | 56 | 4.825 | 792154 | 23.06062398 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales